Sign up to save your podcasts
Or
Share The New Frontier of Combination Therapy for IBD: The VEGA RCT
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The New Frontier of Combination Therapy for IBD: The VEGA RCT
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Bharati Kochar, MD, MS discuss “Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial,” by Feagan BG, Sands BE, Sandborn WJ, et al. Lancet Gastroenterol Hepatol. 2023; 8: 307-20.
View all episodes
By American College of Gastroenterology
4.8
1616 ratings
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Bharati Kochar, MD, MS discuss “Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial,” by Feagan BG, Sands BE, Sandborn WJ, et al. Lancet Gastroenterol Hepatol. 2023; 8: 307-20.
More shows like Evidence-Based GI: An ACG Publication and Podcast
View all
Gut Podcast
7 Listeners
NEJM This Week
318 Listeners
American Journal of Gastroenterology Author Podcasts
71 Listeners
JAMA Clinical Reviews
499 Listeners
The Curbsiders Internal Medicine Podcast
3,328 Listeners
Core IM | Internal Medicine Podcast
1,111 Listeners
The Peter Attia Drive
8,021 Listeners
Annals On Call Podcast
196 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
348 Listeners
Behind the Case: An ACG Case Reports Journal Podcast
6 Listeners
The Lancet Gastroenterology & Hepatology in conversation with
0 Listeners
Listen In: GI Endoscopy
33 Listeners
Gastroenterology Learning Network
10 Listeners
Gastroenterology & Endoscopy
3 Listeners